Search results for "pause"

showing 10 items of 467 documents

Bidirectional associations between cognitive functions and walking performance among middle-aged women

2022

Objective: This study investigated whether (1) cognitive functions change after the transition from the perimenopausal to the postmenopausal stage, (2) cognitive functions and walking are associated in middle-aged women, and (3) cognitive functions assessed in perimenopause are associated with walking after reaching the postmenopause or vice versa. Methods: In total, 342 women, categorized as early (n = 158) or late perimenopausal (n = 184), were included in the study and followed up until postmenopausal. Psychomotor speed, executive functions related to set-shifting and updating, working memory, and visual memory were assessed. Walking was assessed with walking speed, walking distance, and…

kognitiiviset taidotfyysinen kuntonaisettoiminnanohjaus (psykologia)ikääntyminenvaihdevuodetphysical functionsmenopauseexecutive functionskeski-ikäisetkävely
researchProduct

Menopausal Status and Physical Activity Are Independently Associated With Cardiovascular Risk Factors of Healthy Middle-Aged Women: Cross-Sectional a…

2019

Cardiovascular disease (CVD) is the primary cause of mortality in women in developed countries. CVD risk rises with age, yet for women there is a rapid increase in CVD risk that occurs after the onset of menopause. This observation suggests the presence of factors in the middle-aged women that accelerate the progression of CVD independent of chronological aging. Leisure time physical activity (LTPA) is a well-established protective factor against CVD. However, its role in attenuating atherogenic lipid profile changes and CVD risk in post-menopausal women has not been well-established. The present study is part of the Estrogenic Regulation of Muscle Apoptosis (ERMA) study, a population-based…

lcsh:RC648-665vaihdevuodetHDLkolesterolimenopausephysical activitycholesteroltriglyseriditHDL-kolesterolilcsh:Diseases of the endocrine glands. Clinical endocrinologyLDLEndocrinologycardiovascular diseasesydän- ja verisuonitauditfasting blood glucoseLDL-kolesterolitriglyceridesfyysinen aktiivisuusOriginal ResearchFrontiers in Endocrinology
researchProduct

What does the translator do when she takes a moment? : scriptlog-aided analysis of long pauses and dictionary use in a translation process

2010

Käännösprosessin tutkiminen on viime vuosina siirtynyt yhä enemmän lopputekstin tutkimisesta itse prosessin eri osien ja piirteiden tutkimukseen. Tauot ovat yksi tämän prosessin eniten tutkituista piirteistä, mutta tähän asti tutkimukset ovat keskittyneet lähinnä kahden tai maksimissaan viiden sekunnin pituisten taukojen analysointiin. Tämän tutkielman tavoitteena on selvittää, millaista informaatiota käännösprosessin kulusta ja sisällöstä sekä sen kääntäjäkohtaisuudesta saadaan ottamalla tutkimuskohteeksi aiempia tutkimuksia pidemmät tauot sekä sanakirjojen käyttö käännösprosessin aikana. Tämän tutkielman aineisto kerättiin hyödyntämällä tietokoneohjelmaa nimeltä Scriptlog, joka tallentaa …

long pausesScriptlogtranslation processdictionary
researchProduct

The role of physical activity in the link between menopausal status and mental well-being

2020

OBJECTIVE To examine the relationship between menopausal status and mental well-being, and whether this relationship varies as a function of physical activity (PA). METHODS Based on a hormonal analysis and bleeding diary, women aged 47 to 55 were categorized as pre (n = 304), early peri (n = 198), late peri (n = 209), or postmenopausal (n = 387). Mental well-being was assessed using the Centre for Epidemiologic Studies Depression Scale, the International Positive and Negative Affect Schedule Short Form, and the Satisfaction with Life Scale. PA was self-reported and categorized as low, medium, and high. Associations between variables were analyzed using multivariate linear regression adjuste…

masennusmedicine.medical_specialtyaffektiivisuusvaihdevuodetPeriPhysical activityphysical activityPersonal Satisfactionliikunta03 medical and health sciencesdepressive symptoms0302 clinical medicineSurveys and QuestionnairesBayesian multivariate linear regressionmedicineHumans030212 general & internal medicinelife satisfactionExercisemenopausal status030219 obstetrics & reproductive medicineDepressionObstetricsbusiness.industryMental well-beingObstetrics and GynecologyLife satisfactionMiddle Agedmedicine.diseaseConfidence intervalnegative affectivityPerimenopausePostmenopauseMenopauseAffectPremenopausePositive affectivitytyytyväisyysHot Flashespositive affectivityFemalebusinessMenopause
researchProduct

Effects of soy isoflavones on endothelial function in healthy postmenopausal women.

2005

Objective: To evaluate the effects of soy isoflavone administration on endothelial function in healthy postmenopausal women. Design: Sixty naturally postmenopausal women were randomly assigned to receive isoflavone or placebo tablets for 6 months. Endothelium-dependent vasodilatation was measured by brachial reactivity technique along with levels of plasma soluble intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, P-selectin and soluble thrombomodulin, von Willebrand factor, and tissue plasminogen activator. Differences between endothelium-dependent and endothelium-independent vasodilatation were assessed by evaluating brachial reactivity par…

medicine.medical_specialtyAdhesion moleculeEndotheliumBrachial ArteryGenisteinVascular Cell Adhesion Molecule-1PhytoestrogensFibrinogenAdhesion molecule; Endothelial function; Postmenopausal womenchemistry.chemical_compoundVon Willebrand factorInternal medicineMedicineHumansProspective StudiesReactive hyperemiabiologybusiness.industryObstetrics and GynecologyEndothelial functionIsoflavonesMiddle AgedIntercellular Adhesion Molecule-1Postmenopausal womenIsoflavoneGenisteinIsoflavonesDietPostmenopauseVasodilationProspective StudieP-SelectinEndocrinologymedicine.anatomical_structurechemistryPhytoestrogencardiovascular systembiology.proteinFemaleEndothelium VascularSoybeansSoybeanbusinessE-SelectinPlasminogen activatorHumanLipoproteinmedicine.drugMenopause (New York, N.Y.)
researchProduct

Polycystic ovary syndrome: metabolic consequences and long-term management.

2014

Young women with polycystic ovary syndrome (PCOS) present an increased risk for type II diabetes and cardiovascular diseases. The prevalence of altered glucose tolerance ranges between 20 and 35 % in patients while the prevalence of type II diabetes ranges between 2 and 8 % and seems related to body weight and ethnic group. Moving from the young fertile age to the 40s and the menopause the prevalence of type II diabetes continues to increase compared to the general female population and may reach 10-16 % of PCOS women. However, prevalence of altered glucose tolerance does not increase. Also cardiovascular risk is increased in a large part of young PCOS women but this risk tends to be normal…

medicine.medical_specialtyAgingClinical BiochemistryPhysiologyAge DistributionRisk FactorsInternal medicineLong term managementmedicineHumansIn patientbusiness.industryGeneral Medicinemedicine.diseasePolycystic ovaryObesityAndrogen secretionMenopausePostmenopauseYoung ageEndocrinologyIncreased riskDiabetes Mellitus Type 2Cardiovascular DiseasesFemalebusinessPolycystic Ovary SyndromeScandinavian journal of clinical and laboratory investigation. Supplementum
researchProduct

OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area

2013

Protein glycosylation via O-linked N-acetylglucosaminylation (O-GlcNAcylation) is an important post-translational regulatory mechanism mediated by O-GlcNAc transferase (OGT) and responsive to nutrients and stress. OGT attaches an O-GlcNAc moiety to proteins, while O-GlcNAcase (OGA) catalyzes O-GlcNAc removal. In skeletal muscle of experimental animals, prolonged increase in O-GlcNAcylation associates with age and muscle atrophy. Here we examined the effects of hormone replacement therapy (HRT) and power training (PT) on muscle OGT and OGA gene expression in postmenopausal women generally prone to age-related muscle weakness. In addition, the associations of OGT and OGA gene expressions with…

medicine.medical_specialtyAgingGlycosylationTime Factorsmedicine.drug_classPlyometric ExerciseBiologyta3111N-AcetylglucosaminyltransferasesBiochemistryGene Expression Regulation EnzymologicEndocrinologyDownregulation and upregulationInternal medicineGene expressionGeneticsmedicineHumansMuscle StrengthRNA Messengerta315Muscle SkeletalMolecular BiologyFinlandGlyceraldehyde 3-phosphate dehydrogenasePlyometric power trainingEstrogen Replacement Therapyta1182Age FactorsMuscle weaknessSkeletal muscleta3141Cell BiologyMiddle Agedbeta-N-AcetylhexosaminidasesMuscle atrophyPostmenopausePhenotypeTreatment OutcomeEndocrinologymedicine.anatomical_structureEstrogenbiology.proteinFemaleMuscle atrophymedicine.symptomProtein Processing Post-TranslationalMuscle ContractionMuscle contraction
researchProduct

Current management of pelvic organ prolapse in aging women : EMAS clinical guide

2018

Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women are more active than they were in the past, and the development of POP disrupts quality of life and impairs social and personal activities. The menopausal transition is a time of vulnerability, during which many women start experiencing symptoms and signs of POP. The role of hormonal changes or of hormonal therapies in influencing the development or progression of POP has been explored extensively. The management of POP requires considerable clinical skills. Correct diagnosis and characterization of the prolapse and an identification of the individual woman's most bothersome symptoms are the hal…

medicine.medical_specialtyAginggenetic structuresFLOOR DISORDERSUrinary incontinenceUrinary incontinencebehavioral disciplines and activitiesGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialMultidisciplinary approachlawQUALITY-OF-LIFE3123 Gynaecology and paediatricsmedicineHumans030212 general & internal medicineIntensive care medicineGENITOURINARY SYNDROMECompetence (human resources)AgedICS JOINT REPORTPelvic organ030219 obstetrics & reproductive medicineVULVO-VAGINAL ATROPHYbusiness.industryObstetrics and GynecologyLAPAROSCOPIC LATERAL SUSPENSIONERYAG LASER TREATMENTmedicine.diseaseSTRESS URINARY-INCONTINENCEOptimal management3. Good healthPelvic organ prolapseManagementMenopauseAging; Management; Pelvic organ prolapse; Urinary incontinenceCurrent managementPOSTMENOPAUSAL WOMEN3121 General medicine internal medicine and other clinical medicineRANDOMIZED-CONTROLLED-TRIALFemaleMenopausemedicine.symptombusiness
researchProduct

Steroid Receptor Expression in Endometria from Women Treated with Tamoxifen

1998

Abstract Breast cancer patients receiving tamoxifen (Tam) are at an increased risk for developing endometrial carcinomas, possibly due to the partial estrogenic effect of Tam on endometrial cells. Progestational therapy has not routinely been included in Tam regimens. It was our aim to determine the presence of estrogen receptors (ERs) and progesterone receptors (PRs) in normal and abnormal endometria from postmenopausal women with breast cancer who were treated with Tam. Standard immunohistochemical staining of ERs and PRs was performed on paraffin sections from formalin-fixed uterine curettings or hysterectomy specimens from 40 patients who had received 20–40 mg of Tam daily for a minimum…

medicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classReceptor expressionEstrogen receptorBreast NeoplasmsEndometriumEndometriumBreast cancerInternal medicineEndometrial PolypHumansMedicineRetrospective Studiesbusiness.industryObstetrics and Gynecologymedicine.diseasePostmenopauseTamoxifenmedicine.anatomical_structureEndocrinologyReceptors EstrogenOncologyEstrogenAdenocarcinomaFemaleReceptors ProgesteronebusinessTamoxifenmedicine.drugGynecologic Oncology
researchProduct

The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program o…

2013

BACKGROUND Compliance and persistence are often overlooked in adjuvant breast cancer treatment. PATIENTS AND METHODS PACT was a prospective, multicenter, randomized, open, parallel-group study assessing whether educational materials (EMs) enhanced compliance with aromatase inhibitor (AI) therapy in postmenopausal women with early, hormone-receptor-positive (HR+) breast cancer. The primary end points were compliance (proportion taking ≥ 80% anastrozole) at 12 months and persistence (proportion reporting anastrozole intake during the study period). RESULTS Four thousand eight hundred and forty-four patients were randomly assigned 1:1 to receive standard therapy or standard therapy with EMs. T…

medicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classmedicine.medical_treatmentAnastrozoleBreast NeoplasmsAnastrozolePactPersistence (computer science)Medication AdherenceEosinophilia–myalgia syndromeBreast cancerInternal medicineNitrilesmedicineHumansProspective StudiesEarly Detection of CancerAgedGynecologyAromatase inhibitorbusiness.industrySurrogate endpointHematologyMiddle AgedTriazolesmedicine.diseasePostmenopauseOncologyPatient ComplianceFemalebusinessAdjuvantmedicine.drugFollow-Up StudiesAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct